Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.79 |
| ▸ | PPARD | Q03181 | 5/20 | 0.79 |
| ▸ | PPARA | Q07869 | 5/20 | 0.79 |
| ▸ | F7 | P08709 | 5/20 | 0.79 |
| ▸ | F3 | P13726 | 5/20 | 0.79 |
| ▸ | TERT | O14746 | 3/20 | 0.79 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.79 |
| ▸ | FABP4 | P15090 | 3/20 | 0.79 |
| ▸ | TOP1 | P11387 | 3/20 | 0.79 |
| ▸ | MAPT | P10636 | 2/20 | 0.79 |
| ▸ | BLM | P54132 | 2/20 | 0.79 |
| ▸ | LMNA | P02545 | 2/20 | 0.79 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.79 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.79 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.79 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.79 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.79 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.79 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1594581 | 1.00 | PPARG (0.79) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL15325098 | 1.00 | PPARG (0.79) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL10901723 | 1.00 | PPARG (0.79) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL1595888 | 1.00 | PPARG (0.79) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL23455769 | 1.00 | PPARG (0.79) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL16681568 | 1.00 | PPARG (0.79) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL23455768 | 1.00 | PPARG (0.79) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL10901728 | 1.00 | PPARG (0.79) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL18258545 | 1.00 | PPARG (0.79) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL18258541 | 1.00 | PPARG (0.79) | PPARGPPARDPPARAF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025128741-A1 | OCTADECANOID COMPOSITIONS AND METHODS OF ACTIVATING MUCOSAL REPAIR PATHWAYS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-06-19 | — | — | WO | claimed |
| CN-116440112-A | Anti-inflammatory agent containing rare fatty acid | 国立大学法人京都大学 | 2023-07-18 | — | — | CN | claimed |
| US-20210069141-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2021-03-11 | — | — | US | claimed |
| EP-2913051-B1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | UNIV KYOTO (JP) | 2018-09-19 | — | — | EP | claimed |
| US-20170000752-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2017-01-05 | — | — | US | claimed |
| EP-3097910-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | Kyoto University (JP) | 2016-11-30 | — | — | EP | claimed |
| US-20150342916-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | NOSTER INC. (JP) | 2015-12-03 | — | — | US | claimed |
| CN-104902887-A | Metabolism-improving agent comprising rare fatty acid | UNIV KYOTO | 2015-09-09 | — | — | CN | claimed |
| EP-2913051-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | Kyoto University (JP) | 2015-09-02 | — | — | EP | claimed |
| JP-9063902-A | — | — | None | — | — | JP | disclosed |
| EP-4740753-A1 | INTESTINAL REGULATOR | Noster Inc. (JP) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025128741-A1 | OCTADECANOID COMPOSITIONS AND METHODS OF ACTIVATING MUCOSAL REPAIR PATHWAYS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025013799-A1 | INTESTINAL REGULATOR | Ｎｏｓｔｅｒ株式会社 | 2025-01-16 | — | — | WO | disclosed |
| CN-116440112-A | Anti-inflammatory agent containing rare fatty acid | 国立大学法人京都大学 | 2023-07-18 | — | — | CN | disclosed |
| US-20150342916-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | NOSTER INC. (JP) | 2015-12-03 | — | — | US | disclosed |
| CN-104902887-A | Metabolism-improving agent comprising rare fatty acid | UNIV KYOTO | 2015-09-09 | — | — | CN | disclosed |
| EP-2913051-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | Kyoto University (JP) | 2015-09-02 | — | — | EP | disclosed |
| US-20150057461-A1 | METHOD FOR PRODUCING MEDIUM-CHAIN OMEGA-HYDROXY FATTY ACIDS, ALPHA,OMEGA-DICARBOXYLIC ACIDS, AND OMEGA-AMINO FATTY ACIDS FROM LONG-CHAIN FATTY ACIDS BY BIOTRANSFORMATION | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2015-02-26 | — | — | US | disclosed |
| EP-2835425-A1 | METHOD FOR PRODUCING MIDDLE-CHAIN OMEGA-HYDROXY FATTY ACIDS, ALPHA AND OMEGA-DICARBOXYLIC ACIDS, AND OMEGA-AMINO FATTY ACIDS FROM LONG-CHAIN FATTY ACIDS BY BIOTRANSFORMATION | Ewha University-Industry Collaboration Foundation (KR) | 2015-02-11 | — | — | EP | disclosed |
| JP-H0963902-A | ELECTROLYTE OF ELECTROLYTIC CAPACITOR | HITACHI AIC INC | 1997-03-07 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150342916-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | FADS1, FASN, ELOVL1 | PPARG 147/4885PPARD 358/4885PPARA 154/4885 |
| US-20210069141-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | ELOVL1, ELOVL5, ELOVL3 | PPARG 54/4885PPARD 108/4885PPARA 49/4885 |
| US-20170000752-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | ELOVL1, ELOVL5, ELOVL3 | PPARG 54/4885PPARD 108/4885PPARA 49/4885 |
| US-20150057461-A1 | METHOD FOR PRODUCING MEDIUM-CHAIN OMEGA-HYDROXY FATTY ACIDS, ALPHA,OMEGA-DICARBOXYLIC ACIDS, AND OMEGA-AMINO FATTY ACIDS FROM LONG-CHAIN FATTY ACIDS BY BIOTRANSFORMATION | ALOX5, ALOX12, ALOX15 | PPARG 732/4885PPARD 1382/4885PPARA 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.